A surging demand for blood products is drawing the world’s largest suppliers in China, where supplies are limited by strict rules governing blood donation.
Four in 10 insured adults under age 64 said they received an unexpected medical bill in the past year, according to a poll by the Kaiser Family Foundation.
A common theme this earnings season: U.S. business executives are ready to relocate their supply chains if the cost of importing Chinese goods becomes prohibitive.
As a shortage of epinephrine pens continues to grip the U.K., authorities have agreed to extend the expiration date on a second injector to help ease the situation.
If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.
As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.
